[United States] Incyte v. Sun Pharm (Federal Circuit, May 2025)
Updated: Oct 9
Article information
Article type: Case note
Categories: United States
Issues: Injunctions
Published on website: 2026-10-08
Display/classification checked: 2026-10-10
[United States] Incyte v. Sun Pharm (Federal Circuit, May 2025)
A preliminary injunction is available where irreparable harm will be suffered.
Even economic harm may qualify if it cannot readily be compensated as quantifiable monetary damages.
→ In this case, Incyte’s product remained at an early stage of development and could not be brought to market before the patent expired. Irreparable harm was therefore not established.
Original article (2025-09-05):
Originally posted on LinkedIn: https://www.linkedin.com/feed/update/urn:li:activity:7513748084523266048/
Related articles
Consultation guide by purpose: https://www.takaishihideki.com/en/single-post/consultation-guide-en
Update history
The update history records only changes actually published, with dates.
2026-10-08: First publication of the LinkedIn original; display, classification, and consultation link set.
2026-10-10: Updated related-article links. The original article text was not changed.
Comments